A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

NCT00293800 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

173

Enrollment

INDUSTRY

Sponsor class

Conditions

Open-Angle Glaucoma
Ocular Hypertension

Interventions

DRUG: Travoprost 0.004%/Timolol 0.5% Ophthalmic Solution
DRUG: Latanoprost 0.005% Ophthalmic Solution (XALATAN)
DRUG: Timolol 0.5% Ophthalmic Solution
OTHER: Timolol Vehicle

Sponsor

Alcon Research